These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 7516919

  • 1. Peripheral blood stem cell (PBSC) mobilization and transplantation (PSCT) in patients with malignant lymphomas and solid tumors.
    Richel DJ, Van der Wall E, Slaper J, Van der Schoot E, Rodenhuis S.
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():71-5. PubMed ID: 7516919
    [Abstract] [Full Text] [Related]

  • 2. [Favorable effect of hematopoietic stem cells isolated from blood on hematologic recovery following high-dosage chemotherapy].
    Richel DJ, Baars JW, Wijngaarden MJ, van der Schoot CE, Vlasveld LT, Rodenhuis S.
    Ned Tijdschr Geneeskd; 1993 Jan 30; 137(5):245-50. PubMed ID: 7679478
    [Abstract] [Full Text] [Related]

  • 3. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
    Nademanee A, Sniecinski I, Schmidt GM, Dagis AC, O'Donnell MR, Snyder DS, Parker PM, Stein AS, Smith EP, Molina A.
    J Clin Oncol; 1994 Oct 30; 12(10):2176-86. PubMed ID: 7523609
    [Abstract] [Full Text] [Related]

  • 4. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM, Cavo M, Fortuna A.
    J Hematother; 1996 Aug 30; 5(4):339-49. PubMed ID: 8877709
    [Abstract] [Full Text] [Related]

  • 5. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
    Engelhardt M, Winkler J, Waller C, Lange W, Mertelsmann R, Henschler R.
    Bone Marrow Transplant; 1997 Mar 30; 19(6):529-37. PubMed ID: 9181898
    [Abstract] [Full Text] [Related]

  • 6. Effect of CD34+ selection and various schedules of stem cell reinfusion and granulocyte colony-stimulating factor priming on hematopoietic recovery after high-dose chemotherapy for breast cancer.
    Somlo G, Sniecinski I, Odom-Maryon T, Nowicki B, Chow W, Hamasaki V, Leong L, Margolin K, Morgan R, Raschko J, Shibata S, Tetef M, Molina A, Berenson RJ, Forman SJ, Doroshow JH.
    Blood; 1997 Mar 01; 89(5):1521-8. PubMed ID: 9057632
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Application of whole blood and peripheral blood progenitor cells (PBPC) and new strategies for rescue after intensive cyclic chemotherapy in high-risk breast cancer.
    Filip S, Bláha M, Odrázka K, Mericka P, Vávrová J.
    J Hematother Stem Cell Res; 2000 Feb 01; 9(1):31-8. PubMed ID: 10738969
    [Abstract] [Full Text] [Related]

  • 10. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM, Visani G, Leopardi G, Motta MR, Rizzi S, Testoni N, Curti A, Tura S.
    Bone Marrow Transplant; 1999 Feb 01; 23(3):235-41. PubMed ID: 10084254
    [Abstract] [Full Text] [Related]

  • 11. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor.
    Schwartzberg LS, Birch R, Hazelton B, Tauer KW, Lee P, Altemose R, George C, Blanco R, Wittlin F, Cohen J.
    J Hematother; 1992 Feb 01; 1(4):317-27. PubMed ID: 1285381
    [Abstract] [Full Text] [Related]

  • 12. Double-cycle high-dose chemotherapy with peripheral blood stem cells and hematopoietic growth factor support in patients with advanced solid tumor. A pilot study by the Hong Kong Biotherapy Group.
    Yeung AW, Pang YK, Tsang YC, Wong SW.
    Cancer; 1994 Apr 01; 73(7):1960-70. PubMed ID: 7511042
    [Abstract] [Full Text] [Related]

  • 13. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
    Weisdorf D, Miller J, Verfaillie C, Burns L, Wagner J, Blazar B, Davies S, Miller W, Hannan P, Steinbuch M, Ramsay N, McGlave P.
    Biol Blood Marrow Transplant; 1997 Oct 01; 3(4):217-23. PubMed ID: 9360784
    [Abstract] [Full Text] [Related]

  • 14. Peripheral blood stem cell mobilization with chemotherapy and granulocyte-colony stimulating factor in patients with hematological malignancies.
    Watanabe S, Mukaiyama T, Ogawa Y, Kawada H, Ichikawa Y.
    Tokai J Exp Clin Med; 1994 Dec 01; 19(3-6):143-55. PubMed ID: 7570686
    [Abstract] [Full Text] [Related]

  • 15. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G, Lemoli R, Tosi P, Martinelli G, Testoni N, Ricci P, Motta M, Gherlinzoni F, Leopardi G, Pastano R, Rizzi S, Piccaluga P, Isidori A, Tura S.
    Bone Marrow Transplant; 1999 Sep 01; 24(5):467-72. PubMed ID: 10482929
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma.
    Demirer T, Buckner CD, Gooley T, Appelbaum FR, Rowley S, Chauncey T, Lilleby K, Storb R, Bensinger WI.
    Bone Marrow Transplant; 1996 Jun 01; 17(6):937-41. PubMed ID: 8807097
    [Abstract] [Full Text] [Related]

  • 18. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H, Mulder NH, Willemse PH, van der Graaf WT, Sleijfer DT, Zijlstra JG, Elias M, Sibinga CT, Vellenga E, de Vries EG.
    Anticancer Res; 1995 Jun 01; 15(6B):2851-6. PubMed ID: 8669878
    [Abstract] [Full Text] [Related]

  • 19. Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells.
    Knudsen LM, Gaarsdal E, Jensen L, Nielsen KJ, Nikolaisen K, Johnsen HE.
    J Hematother; 1996 Aug 01; 5(4):399-406. PubMed ID: 8877715
    [Abstract] [Full Text] [Related]

  • 20. Recombinant human granulocyte colony-stimulating factor infusion and/or autologous peripheral blood stem cell transplantation as a rescue for sequential high-dose combination chemotherapy: a preliminary report.
    Chau WK, Lin CK, Chow MP, Wang SY, Liu JM, Ho CH, Chiu CF, Hsu HC, Tan TD, Chan WK.
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Nov 01; 54(5):312-20. PubMed ID: 7530591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.